Connect with us

Business News

Flowserve Corporation kondigt de start aan van het Overnamebod voor zijn 1,250% niet-achtergestelde Obligaties die vervallen in 2022

Published

on

ADVERTISEMENT


DALLAS, VS–()–Flowserve Corporation (NYSE: FLS) (de ‘Bieder‘), Een toonaangevende leverancier van producten en diensten op het gebied van flow control voor de wereldwijde infrastructuurmarkten, kondigde een Bod (een dergelijk bod, de ‘Bod‘) aan om alle uitstaande 1,250% niet-achtergestelde Obligaties die vervallen op 17 maart 2022 (de ‘Obligaties’) van de houders van de Obligaties (elk, een ‘Obligatiehouder‘ en, gezamenlijk, de ‘Obligatiehouders‘) tegen contant geld te kopen. Op de voorwaarden en onder de condities uiteengezet in het Overnamebodmemorandum van 14 september 2020 (zoals het van tijd tot tijd kan worden aangevuld of gewijzigd) (de ‘Overnamebodmemorandum‘), inclusief de begeleidende kennisgeving van…



Click here to view the original article.

Business News

The Law Offices of Frank R. Cruz Announces Investigation of NextCure, Inc. (NXTC) on Behalf of Investors

Published

on

ADVERTISEMENT


LOS ANGELES–()–The Law Offices of Frank R. Cruz announces an investigation of NextCure, Inc. (“NextCure” or the “Company”) (NASDAQ: NXTC) on behalf of investors concerning the Company’s possible violations of federal securities laws.

If you are a shareholder who suffered a loss, click here to participate.

On January 13, 2020, NextCure disclosed that Eli Lilly and Company had ended its collaboration agreement for the research and development of the Company’s leading product candidate, NC318, a first-in-class immunomedicine targeting the Siglec-15 immunomodulatory receptor particularly for patients with advanced or metastatic solid tumors.

On this news, the Company’s share price fell $4.70, or…



Click here to view the original article.

Continue Reading

Business News

Infogain Partners with Appvance to Offer AI-driven Advanced Automated Testing

Published

on

AON Splash Image
ADVERTISEMENT


LOS GATOS, Calif.–()–Infogain, a leading provider of technology solutions and an expert in software platform engineering, has announced a strategic partnership with Appvance.ai, the leader in AI-driven test generation. The new partnership will help global businesses tap into the disruptive power of AI-led quality engineering services.

This partnership will strengthen Infogain’s PAQman solutions, which use machine learning driven predictive analytics to enable advanced automated testing. The PAQman Automation module reduces test creation effort by 60%, enabling the use of a single script across all web and mobile OS platforms with multi-locator features. Furthermore, it keeps ‘dev’ and ‘test’ in sync…



Click here to view the original article.

Continue Reading

Business News

REPAY Announces Closing of Over-Allotment Option in Public Offering of Common Stock

Published

on

AON Splash Image
ADVERTISEMENT


ATLANTA–()–Repay Holdings Corporation (NASDAQ: RPAY) (“REPAY” or the “Company”) today announced that the underwriter of its previously announced registered underwritten public offering of 13,000,000 shares of its Class A common stock fully exercised its over-allotment option to purchase an additional 1,364,816 shares of Class A common stock from the Company. The offering of the additional shares of Class A common stock pursuant to the over-allotment option closed today.

All of the proceeds (before expenses) from the closing of the over-allotment option were used to acquire a number of units equivalent to the number of shares of Class A common stock sold, such units representing limited liability company…



Click here to view the original article.

Continue Reading

Trending

You might also like ...

AON Splash Image
Laird Superfood Announces Pricing of Initial Public Offering
Workiva sluit Amplify 2020 af: wereldwijde conferentie omgevormd tot een virtuele ervaring voor meer dan 6.000 deelnemers in 60 landen
Tula Presents dDSF Technology at Future Diesel Powertrain Summit in Shanghai